This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Alere Inc. provides point-of-care diagnostics and services for infectious and cardiometabolic diseases, and toxicology and in the United States and internationally. It operates in three segments: Professional Diagnostics, Patient Self-Testing, and Consumer Diagnostics.View ALR key stats
Alere Inc - ALR - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Alere Inc as a
Hold with a ratings score of C+.
Report Snippet: We rate ALERE INC (ALR) a HOLD. The primary factors that have impacted our rating are mixed - some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks. The company's strengths can be seen in multiple areas, such as its solid stock price performance, compelling growth in net income and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity, weak operating cash flow and generally higher debt management risk.